Lv3
248 积分 2021-08-12 加入
[Universal chimeric antigen receptor T cells therapy: current status and future perspectives]
7小时前
待确认
Therapy with oncolytic viruses: progress and challenges
2个月前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2个月前
已完结
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
4个月前
已完结
CD4+ T cell memory
6个月前
已完结
Two parallel worlds of memory T cells
6个月前
已完结
Gene-engineered T cells for cancer therapy
6个月前
已完结
Metabolic waypoints during T cell differentiation
8个月前
已完结
Optimizing the manufacturing and antitumour response of CAR T therapy
9个月前
已完结
Release Assays and Potency Assays for CAR T-Cell Interventions
9个月前
已完结
皖公网安备34019202002308
